Respiratory Syncytial Virus Immune Globulin Treatment of RSV Lower Respiratory Tract Infection in Previously Healthy Children
Authors:
- the RSV-IGIV Study GroupTGthe RSV-IGIV Study Group
- 1 December 1997
- journal article
- clinical trial
- Published by American Academy of Pediatrics (AAP) in Pediatrics
- Vol. 100 (6) , 937-942
Abstract
Objective. To evaluate the efficacy of high titer respiratory syncytial virus (RSV) immune globulin (RSVIG) in the treatment of previously healthy children hospitalized with proven RSV lower tract infection (LRI).Keywords
This publication has 24 references indexed in Scilit:
- Reduction of Respiratory Syncytial Virus Hospitalization Among Premature Infants and Infants With Bronchopulmonary Dysplasia Using Respiratory Syncytial Virus Immune Globulin ProphylaxisPediatrics, 1997
- Treatment of Parainfluenza Virus Type 3 Bronchiolitis and Pneumonia in a Cotton Rat Model Using Topical Antibody and GlucocorticosteroidThe Journal of Infectious Diseases, 1996
- Comparison of Antibody Concentrations and Protective Activity of Respiratory Syncytial Virus Immune Globulin and Conventional Immune GlobulinThe Journal of Infectious Diseases, 1994
- Interference of immune globulin with measles and rubella immunizationThe Journal of Pediatrics, 1993
- Improved outcome of respiratory syncytial virus infection in a high-risk hospitalized population of Canadian childrenThe Journal of Pediatrics, 1992
- Respiratory Syncytial Viral Infection in Children with Compromised Immune FunctionNew England Journal of Medicine, 1986
- Immunoprophylaxis and immunotherapy of respiratory syncytial virus infection in the cotton ratVirus Research, 1985
- Aerosolized Ribavirin Treatment of Infants with Respiratory Syncytial Viral InfectionNew England Journal of Medicine, 1983
- RESPIRATORY SYNCYTIAL VIRUS INFECTION IN YOUNG HOSPITALIZED CHILDRENActa Paediatrica, 1983
- Respiratory Syncytial Viral Infection in Infants with Congenital Heart DiseaseNew England Journal of Medicine, 1982